8 results on '"Asad Junaid"'
Search Results
2. A tea/vanadate decoction delivered orally over 14 months to diabetic rats induces long-term glycemic stability without organ toxicity
- Author
-
Grant N. Pierce, James A. Thliveris, Floribeth Aguilar, Donald D. Smyth, Clayton E. Heyliger, Asad Junaid, Tod A. Clark, Hae K. Kim, Andrea L. Edel, Michele A Merchant, and Melanie A. Kopilas
- Subjects
Blood Glucose ,Male ,medicine.medical_specialty ,Endocrinology, Diabetes and Metabolism ,Drinking ,Decoction ,Kidney Function Tests ,Diabetes Mellitus, Experimental ,Rats, Sprague-Dawley ,Eating ,Islets of Langerhans ,Endocrinology ,Liver Function Tests ,Oral administration ,Internal medicine ,Diabetes mellitus ,Animals ,Hypoglycemic Agents ,Insulin ,Medicine ,Adverse effect ,Triglycerides ,Glycemic ,Glycated Hemoglobin ,Type 1 diabetes ,Tea ,business.industry ,Type 2 Diabetes Mellitus ,medicine.disease ,Rats ,Cholesterol ,Amylases ,Toxicity ,Vanadates ,business - Abstract
Vanadium can induce potent hypoglycemic effects in type 1 and type 2 diabetes mellitus animals, but toxic adverse effects have inhibited the translation of these findings. Administration of vanadate in a black tea decoction has shown impressive hypoglycemic effects without evidence of toxicity in short-term studies. The purpose of this study was to investigate the hypoglycemic action and the toxic adverse effects of a tea/vanadate (T/V) decoction in diabetic rats over a 14-month treatment period. Streptozotocin-induced type 1 diabetes mellitus rats were orally gavaged with 40 mg sodium vanadate in a black tea decoction only when blood glucose levels were greater than 10 mmol/L. Glycemic status and liver and kidney function were monitored over 14 months. All of the diabetic rats in this treatment group (n = 25) required treatment with the T/V decoction at the start of the study to reduce blood glucose levels to less than 10 mmol/L. Diarrhea was uncommon among the T/V-treated animals during the first week of T/V treatment and was absent thereafter. There was no evidence of liver or kidney dysfunction or injury. From 2 to 6 months, fewer animals required the T/V treatment to maintain their blood glucose levels. After 9 months of treatment, none of the diabetic animals required any T/V to maintain their blood glucose levels at less than 10 mmol/L. Oral administration of a T/V decoction provides safe, long-acting hypoglycemic effects in type 1 diabetes mellitus rats. The typical glycemic signs of diabetes were absent for the last 5 months of the study.
- Published
- 2012
- Full Text
- View/download PDF
3. TGF-β1, regulation of Alzheimer amyloid precursor protein mRNA expression in a normal human astrocyte cell line: mRNA stabilization
- Author
-
Francis M Amara, Richard R. Clough, Asad Junaid, and Binhua Liang
- Subjects
Chloramphenicol O-Acetyltransferase ,Untranslated region ,medicine.medical_specialty ,Transcription, Genetic ,Recombinant Fusion Proteins ,Biology ,Transfection ,Cell Line ,Amyloid beta-Protein Precursor ,Cellular and Molecular Neuroscience ,Transforming Growth Factor beta ,Internal medicine ,mental disorders ,Gene expression ,Amyloid precursor protein ,medicine ,Animals ,Humans ,Coding region ,RNA, Messenger ,3' Untranslated Regions ,Molecular Biology ,Messenger RNA ,Brain ,Templates, Genetic ,MRNA stabilization ,Rats ,Cell biology ,Kinetics ,medicine.anatomical_structure ,Endocrinology ,Gene Expression Regulation ,Astrocytes ,biology.protein ,Neuroglia ,Astrocyte - Abstract
The transforming growth factor, TGF-beta(1), has been found to be increased in the central nervous system of Alzheimer's disease (AD) patients, elevates amyloid precursor protein (APP) mRNA levels in rat primary astrocytes, and may initiate or promote the deposition of amyloid-beta (Abeta) peptide in AD. Excess APP production in AD, which potentially leads to amyloidogenesis, is in part due to over expression of APP mRNA. The production of APP in a normal human cell line in contrast to transformed or animal cells provides a meaningful model to study the regulation of APP gene expression by cytokines that promotes amyloidogenesis. Here, we report that TGF-beta(1) treatment of human astrocytes markedly elevated APP mRNA levels, and also increased the half-life of APP message by at least five-fold. Under this condition, as detected by mobility shift and UV cross-linking analysis, a novel 68 kDa RNA-protein complex was formed, involving an 81 nucleotide (nt) fragment within the 3'-untranslated region (UTR), but not the 5'-UTR and coding region of APP mRNA. Insertion of the 3'-UTR onto the chloramphenicol acetyl transferase (CAT) mRNA conferred TGF-beta(1) mediated mRNA stability in transfected human astrocytes. On the other hand, the same insert carrying a deletion of the APP mRNA cis-element fragment had no effect on CAT mRNA stability. A model of APP mRNA regulation is presented in which TGF-beta(1) induced stabilization of APP message involves the binding activity of a 68 kDa RNA-protein complex within the 3'-UTR, which is likely linked to a reduction in the rate of APP mRNA decay.
- Published
- 1999
- Full Text
- View/download PDF
4. Elevation of Expression of Smads 2, 3, and 4, Decorin and TGF-βin the Chronic Phase of Myocardial Infarct Scar Healing
- Author
-
Haisong Ju, Ian M.C. Dixon, Asad Junaid, Shufang Zhao, Tracy Scammell-La Fleur, and Jianming Hao
- Subjects
Male ,Pathology ,medicine.medical_specialty ,Decorin ,Cardiac fibrosis ,Blotting, Western ,Myocardial Infarction ,Receptor, Transforming Growth Factor-beta Type I ,Fluorescent Antibody Technique ,Enzyme-Linked Immunosorbent Assay ,Smad2 Protein ,SMAD ,Protein Serine-Threonine Kinases ,Rats, Sprague-Dawley ,Extracellular matrix ,Cicatrix ,Transforming Growth Factor beta ,TGF beta signaling pathway ,medicine ,Animals ,Smad3 Protein ,Molecular Biology ,Smad4 Protein ,Extracellular Matrix Proteins ,Chemistry ,Myocardium ,Hemodynamics ,Receptor, Transforming Growth Factor-beta Type II ,Heart ,medicine.disease ,Rats ,DNA-Binding Proteins ,Disease Models, Animal ,Trans-Activators ,Proteoglycans ,Collagen ,Cardiology and Cardiovascular Medicine ,Wound healing ,Activin Receptors, Type I ,Receptors, Transforming Growth Factor beta ,Immunostaining - Abstract
We have previously shown that non-myocytes present in healed 8-week infarct scar overexpress transduction proteins required for initiating the elevated deposition of structural matrix proteins in this tissue. Other work suggests that TGF-beta 1 may be involved in cardiac fibrosis and myocyte hypertrophy. However, the significance of the altered TGF-beta signaling in heart failure in the chronic phase of post-myocardial infarction (MI), particularly in the ongoing remodeling of the infarct scar, remains unexplored. Patterns of cardiac TGF beta 1 and Smad 2, 3, and 4 protein expression were investigated 8 weeks after MI and were compared to relative collagen deposition in border tissues (containing remnent myocytes) and the infarct scar (non-myocytes). Both TGF-beta 1 mRNA abundance and protein levels were significantly increased in the infarct scar v control values, and this trend was positively correlated to increased collagen type I expression. Cardiac Smad 2, 3, and 4 proteins were significantly increased in border and scar tissues v control values. Immunofluorescent studies indicated that Smad proteins localized proximal to the cellular nuclei present in the infarct scar. Decorin mRNA abundance was elevated in border and infarct scar, and the pattern of decorin immunostaining was markedly altered in remote remnant heart and scar v staining patterns of control sections. Expression of T beta RI (53 kDa) protein was significantly reduced in the scar, while the 75 kDa and 110 kDa isoforms of T beta RII were unchanged and significantly increased in scar, respectively. These results indicate that TGF-beta/Smad signaling may be involved in the remodeling of the infarct scar after the completion of wound healing per se, via ongoing stimulation of matrix deposition.
- Published
- 1999
- Full Text
- View/download PDF
5. Osteopontin localizes to the nucleus of 293 cells and associates with polo-like kinase-1
- Author
-
Asad Junaid, Peter Zahradka, Gregory E. J. Harding, and Michael C. Moon
- Subjects
Physiology ,Immunoprecipitation ,Cell Cycle Proteins ,Polo-like kinase ,DNA-Directed DNA Polymerase ,Protein Serine-Threonine Kinases ,Cell Line ,stomatognathic system ,Aphidicolin ,Proto-Oncogene Proteins ,Humans ,Osteopontin ,Nucleic Acid Synthesis Inhibitors ,Cell Nucleus ,biology ,HEK 293 cells ,Cell Cycle ,Cell Biology ,Cell cycle ,Cell biology ,Tumor progression ,Phosphoprotein ,Mutation ,biology.protein ,Intracellular ,Protein Binding - Abstract
Osteopontin (OPN) is a secreted phosphoprotein involved in cellular proliferation and associated with tumor progression. Although an intracellular form of OPN has been described, its function remains unknown. In this study, a novel nuclear location for intracellular OPN and a correlation with cell division were demonstrated. OPN distinctly localized to the nucleus in a subset of transiently transfected human embryonic kidney 293 cells. Immunoblotting confirmed the nuclear location of native OPN, and results from immunofluorescence studies suggested an association between nuclear OPN and cell cycle progression. Flow cytometry revealed that nuclear and cellular OPN content rose significantly during the S and G2/M phases, respectively. Treatment of cells with the DNA polymerase inhibitor aphidicolin prevented cell cycling and greatly reduced cellular OPN content. The intracellular location of OPN coincided with polo-like kinase-1 (Plk-1), a member of the polo-like kinase family, which, in part through their regulation of centrosome-related events, are integral to successful cellular mitosis. OPN and Plk-1 were coimmunoprecipitated from nuclear, but not cystoslic, extracts, demonstrating an interaction that is limited to the nucleus, presumably during mitosis. Deletion of the COOH terminus of OPN militated against nuclear localization and Plk-1 interaction. Elevated expression of OPN was also associated with an increase in the number of multinucleate 293 cells, whereas transfection of the COOH-terminal-deleted OPN decreased the percentage of multinucleate cells below basal levels. These findings implicate intranuclear OPN as a participant in the process of cell duplication.
- Published
- 2006
6. Canadian Cardiovascular Society Consensus Conference: peripheral arterial disease - executive summary
- Author
-
Beth L, Abramson, Vic, Huckell, Sonia, Anand, Tom, Forbes, Anil, Gupta, Ken, Harris, Asad, Junaid, Tom, Lindsay, Finlay, McAlister, Andre, Roussin, Jacqueline, Saw, Koon Kang, Teo, Alexander G, Turpie, and Subodh, Verma
- Subjects
Peripheral Vascular Diseases ,Risk Factors ,Humans ,Arterial Occlusive Diseases ,Renal Artery Obstruction ,Aortic Aneurysm - Abstract
This Consensus Conference has been supported by the Canadian Cardiovascular Society. The process is dynamic, with intentional structure that requires peer review and feedback from cardiovascular specialists across Canada. The writing and review panel encompassed a broad range of specialists caring for the patient with peripheral arterial disease (PAD). PAD is an often asymptomatic, underdiagnosed, under-recognized and undertreated condition. It is associated with significant morbidity and cardiac mortality. Until recently, little attention has focused on the evaluation and treatment of the disease process itself. The goal of the present paper is to ensure better treatment, to reduce both morbidity and mortality in the patient with vascular disease and, importantly, to serve as a guide to the busy clinician. Although the focus is PAD, there are chapters on thoracic and abdominal aortic disease, renal arterial disease and the evidence supporting management. Screening and diagnostic techniques including history and physical examination as well as noninvasive imaging techniques are reviewed. Medical management for patients with vascular disease including prevention and risk reduction is graded based on evidence, including both pharmacological and nonpharmacological management strategies, followed by an introduction to newer percutaneous techniques. Finally, surgical treatment for claudication including new concepts on the perioperative risk assessment for patients undergoing major vascular surgery is discussed.
- Published
- 2005
7. McAdvertising and children: fast food television advertisement strategies and reception by preschoolers
- Author
-
Afshan Asad Junaid, Chua, Siew Keng, and Wee Kim Wee School of Communication and Information
- Subjects
Social sciences::Mass media::Broadcasting::TV [DRNTU] ,Social sciences::Communication::Promotional communication [DRNTU] - Abstract
This is a study of the relationship between fast food (especially McDonald’s) advertisement strategies on Singapore television and their reception by preschoolers (aged four to six) in relation to the fast food habits of children. The research was conducted with 36 children at two care centers in Singapore. The reception of television fast food advertisements by these children was studied using ethnographic in-depth interviews. Master of Communication Studies
- Published
- 2003
8. Angiotensin II stimulates phosphorylation and nuclear accumulation of R-Smad 2 in cultured cardiac fibroblasts
- Author
-
Linda M. McLatchie, Thomas Netticadan, Asad Junaid, Baiqiu Wang, Julie C. Roth, Jane V. Harper, Grant N. Pierce, Leanne L. Cribbs, Michael J. Shattock, Ian M.C. Dixon, Edward Perez-Reyes, Gavin Brooks, Stephen C. Jones, and Jianming Hao
- Subjects
Nuclear accumulation ,medicine.medical_specialty ,Angiotensin receptor ,R-SMAD ,Endocrinology ,Angiotensin II receptor type 1 ,Chemistry ,Internal medicine ,medicine ,Phosphorylation ,Cardiology and Cardiovascular Medicine ,Molecular Biology ,Angiotensin II - Published
- 2001
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.